Dementia Clinical Trials in Chicago, Illinois

4 studies are recruiting for dementia in Chicago, Illinois right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. Pragmatic Evaluation of Events And Benefits of Lipid-lowering in Older Adults

    PREVENTABLE is a multi-center, randomized, parallel group, placebo-controlled superiority study. Participants will be randomized 1:1 to atorvastatin 40 mg or placebo. This large study conducted in community-dwelling older adults without cardiovascular disease (CVD) or dementia will demonstrate the …

    Stage
    Phase 4
    Ages
    75 and older
    Site
    Northwestern University, Chicago, Illinois
    Locations
    106 in total
    Run by
    Duke University

    See if you can join NCT04262206 on ClinicalTrials.gov

  2. Medication Collaboration Feasibility Study

    This study examines the feasibility and acceptability of a brief medication collaboration intervention among older adults (age 60+) with early-stage dementia or mild cognitive impairment who take multiple medications and their family caregivers. The main aims are to: 1) determine the feasibility an…

    Stage
    Not phased
    Ages
    60 and older
    Site
    Northwestern University, Chicago, Illinois
    Run by
    Northwestern University

    See if you can join NCT07742189 on ClinicalTrials.gov

  3. A Study of Donanemab (LY3002813) in Participants Who Completed Study AACM (TRAILBLAZER-ALZ 3-EXT).

    The main purpose of this study is to determine if participants who previously took donanemab get clinical benefit when they receive annual doses. For each participant, the study will last up to 2.5 years and will include 6 visits.

    Stage
    Phase 3
    Ages
    55 and older
    Site
    Great Lakes Clinical Trials - Andersonville, Chicago, Illinois
    Locations
    59 in total
    Run by
    Eli Lilly and Company

    See if you can join NCT07602582 on ClinicalTrials.gov

  4. Development of a Personalized, Psychosocial Intervention for Menopausal Individuals With Elevated Dementia Risk

    By age 45, women's lifetime risk of dementia is estimated to be 1 in 5. Two-thirds of people currently living with a dementia diagnosis are women, and-women make up the majority of carers for people with dementia. Because women bear a larger burden of the dementia epidemic, they tend to be more fea…

    Stage
    Not phased
    Ages
    40 to 58
    Site
    University of Chicago Medicine, Chicago, Illinois
    Run by
    University of Chicago

    See if you can join NCT06965686 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.